Development of chick cardiomyocytes: modulation of intermediate filaments by basic fibroblast and platelet-derived growth factors.
Recent studies suggest that peptide growth factors play a functional role in cardiac muscle. To test whether embryonic cardiac muscle is a target for regulation by basic fibroblast growth factor and platelet-derived growth factor, we analyzed the effects of these peptides on the expression of the intermediate filaments desmin and vimentin at the subcellular level during development. Sodium dodecyl sulfate-gel electrophoresis, immunoblotting and fluorescence-activated cell sorting analysis were used to study the effect of basic fibroblast growth factor and platelet-derived growth factor on cultures of chick cardiomyocytes during development. Cytoplasmic and cytoskeletal concentrations of desmin and vimentin were dependent on the stage of embryonic development and on the type of growth factor added to the culture. The most significant finding was the increase in desmin expression in the cytoplasmic and cytoskeletal compartments after treatment with basic fibroblast growth factor (10 ng/ml) of chick heart cells at Hamburger and Hamilton stage 19. In more mature stages, basic fibroblast growth factor did not modify the levels of desmin expression. However, this factor led to a progressive deceleration in the rate of increase in vimentin expression. Platelet-derived growth factor increased vimentin expression in all stages studied, the greatest increases appearing in early stages of heart development. Our findings support the hypothesis that basic fibroblast growth factor plays a role in cardiomyocyte differentiation during the early stages of development, whereas platelet-derived growth factor has a dedifferentiating effect.
Vélez
C
C
Department of Health Sciences, University of Almería, Spain.
Aránega
A E
AE
Marchal
J A
JA
Melguizo
C
C
Prados
J C
JC
Carrillo
E
E
Aránega
A
A
D000818:Animals; D002478:Cells, Cultured; D002642:Chick Embryo; D003893:Desmin / Q000032:analysis / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects* / Q000196:embryology; D015151:Immunoblotting; D007381:Intermediate Filament Proteins / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D014746:Vimentin / Q000032:analysis / Q000378:metabolism
D003893:Desmin; D007381:Intermediate Filament Proteins; D010982:Platelet-Derived Growth Factor; D014746:Vimentin; D016222:Fibroblast Growth Factor 2